questionsmedicales.fr
Régions géographiques
Afrique
Afrique du Nord
Afrique du Nord : Questions médicales fréquentes
Diagnostic
5
Paludisme
Diagnostic médical
Tuberculose
Tests diagnostiques
Hépatite virale
Diagnostic médical
Schistosomiase
Diagnostic médical
Symptômes
5
Hépatite virale
Symptômes
Prévention
5
Hépatite virale
Prévention
Schistosomiase
Prévention
Traitements
5
Hépatite virale
Traitement
Schistosomiase
Traitement
Complications
5
Tuberculose
Complications
Hépatite virale
Complications
Schistosomiase
Complications
Facteurs de risque
5
Paludisme
Facteurs de risque
Tuberculose
Facteurs de risque
Hépatite virale
Facteurs de risque
Schistosomiase
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Afrique du Nord : Questions médicales les plus fréquentes",
"headline": "Afrique du Nord : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Afrique du Nord : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-27",
"dateModified": "2025-11-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Afrique du Nord"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Afrique",
"url": "https://questionsmedicales.fr/mesh/D000349",
"about": {
"@type": "MedicalCondition",
"name": "Afrique",
"code": {
"@type": "MedicalCode",
"code": "D000349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.058"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Algérie",
"alternateName": "Algeria",
"url": "https://questionsmedicales.fr/mesh/D000462",
"about": {
"@type": "MedicalCondition",
"name": "Algérie",
"code": {
"@type": "MedicalCode",
"code": "D000462",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.058.266.104"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Égypte",
"alternateName": "Egypt",
"url": "https://questionsmedicales.fr/mesh/D004534",
"about": {
"@type": "MedicalCondition",
"name": "Égypte",
"code": {
"@type": "MedicalCode",
"code": "D004534",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.058.266.317"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Libye",
"alternateName": "Libya",
"url": "https://questionsmedicales.fr/mesh/D008002",
"about": {
"@type": "MedicalCondition",
"name": "Libye",
"code": {
"@type": "MedicalCode",
"code": "D008002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.058.266.513"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maroc",
"alternateName": "Morocco",
"url": "https://questionsmedicales.fr/mesh/D009018",
"about": {
"@type": "MedicalCondition",
"name": "Maroc",
"code": {
"@type": "MedicalCode",
"code": "D009018",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.058.266.629"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tunisie",
"alternateName": "Tunisia",
"url": "https://questionsmedicales.fr/mesh/D014416",
"about": {
"@type": "MedicalCondition",
"name": "Tunisie",
"code": {
"@type": "MedicalCode",
"code": "D014416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.058.266.887"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Afrique du Nord",
"alternateName": "Africa, Northern",
"code": {
"@type": "MedicalCode",
"code": "D000352",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Nontokozo D Matume",
"url": "https://questionsmedicales.fr/author/Nontokozo%20D%20Matume",
"affiliation": {
"@type": "Organization",
"name": "HIV/AIDS & Global Health Research Program, University of Venda, Thohoyandou, South Africa."
}
},
{
"@type": "Person",
"name": "Denis M Tebit",
"url": "https://questionsmedicales.fr/author/Denis%20M%20Tebit",
"affiliation": {
"@type": "Organization",
"name": "HIV/AIDS & Global Health Research Program, University of Venda, Thohoyandou, South Africa."
}
},
{
"@type": "Person",
"name": "Peter N Thompson",
"url": "https://questionsmedicales.fr/author/Peter%20N%20Thompson",
"affiliation": {
"@type": "Organization",
"name": "Epidemiology Section, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa."
}
},
{
"@type": "Person",
"name": "Maretha le Roux",
"url": "https://questionsmedicales.fr/author/Maretha%20le%20Roux",
"affiliation": {
"@type": "Organization",
"name": "Department of Nutrition and Dietetics, University of the Free State, Bloemfontein, South Africa."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identifying signatures of positive selection in human populations from North Africa.",
"datePublished": "2023-05-20",
"url": "https://questionsmedicales.fr/article/37210386",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-35312-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genome Tunisia Project: paving the way for precision medicine in North Africa.",
"datePublished": "2024-08-27",
"url": "https://questionsmedicales.fr/article/39187811",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13073-024-01365-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cannabis use in sub-Saharan Africa: A systematic review and meta-analysis.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36807954",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/add.16170"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mucopolysaccharidosis type I: founder effect of the p.P533R mutation in North Africa.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39385097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12864-024-10724-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "The burden of schizophrenia in the Middle East and North Africa region, 1990-2019.",
"datePublished": "2024-04-27",
"url": "https://questionsmedicales.fr/article/38678101",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-59905-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Afrique",
"item": "https://questionsmedicales.fr/mesh/D000349"
},
{
"@type": "ListItem",
"position": 4,
"name": "Afrique du Nord",
"item": "https://questionsmedicales.fr/mesh/D000352"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Afrique du Nord - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Afrique du Nord",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Afrique du Nord",
"description": "Comment diagnostiquer le paludisme en Afrique du Nord ?\nQuels tests pour la tuberculose en Afrique du Nord ?\nComment identifier une infection par le VIH ?\nQuels sont les signes d'une hépatite virale ?\nComment diagnostiquer la schistosomiase ?",
"url": "https://questionsmedicales.fr/mesh/D000352#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Afrique du Nord",
"description": "Quels sont les symptômes du paludisme ?\nQuels signes d'une infection par le VIH ?\nQuels symptômes de la tuberculose ?\nQuels sont les symptômes de la schistosomiase ?\nQuels signes d'hépatite virale ?",
"url": "https://questionsmedicales.fr/mesh/D000352#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Afrique du Nord",
"description": "Comment prévenir le paludisme ?\nQuelles mesures pour prévenir la tuberculose ?\nComment prévenir l'hépatite virale ?\nQuelles stratégies pour prévenir le VIH ?\nComment prévenir la schistosomiase ?",
"url": "https://questionsmedicales.fr/mesh/D000352#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Afrique du Nord",
"description": "Quel traitement pour le paludisme ?\nComment traiter la tuberculose ?\nQuel traitement pour l'hépatite virale ?\nComment traiter une infection par le VIH ?\nQuel traitement pour la schistosomiase ?",
"url": "https://questionsmedicales.fr/mesh/D000352#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Afrique du Nord",
"description": "Quelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications de l'hépatite virale ?\nQuelles complications du VIH ?\nQuelles complications de la schistosomiase ?",
"url": "https://questionsmedicales.fr/mesh/D000352#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Afrique du Nord",
"description": "Quels sont les facteurs de risque du paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels sont les facteurs de risque de l'hépatite virale ?\nQuels facteurs de risque pour le VIH ?\nQuels sont les facteurs de risque de la schistosomiase ?",
"url": "https://questionsmedicales.fr/mesh/D000352#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le paludisme en Afrique du Nord ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter le parasite du paludisme."
}
},
{
"@type": "Question",
"name": "Quels tests pour la tuberculose en Afrique du Nord ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la radiographie pulmonaire et le test cutané à la tuberculine."
}
},
{
"@type": "Question",
"name": "Comment identifier une infection par le VIH ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage se fait par des tests sanguins spécifiques pour les anticorps du VIH."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une hépatite virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, jaunisse et douleurs abdominales, confirmés par des tests sanguins."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer la schistosomiase ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par l'analyse des selles ou des urines pour détecter les œufs du parasite."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du paludisme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, frissons, maux de tête et fatigue intense."
}
},
{
"@type": "Question",
"name": "Quels signes d'une infection par le VIH ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes précoces incluent fièvre, fatigue, et ganglions lymphatiques enflés."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la tuberculose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux persistante, perte de poids, et sueurs nocturnes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la schistosomiase ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleurs abdominales, diarrhée et sang dans les urines."
}
},
{
"@type": "Question",
"name": "Quels signes d'hépatite virale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent jaunisse, fatigue, douleurs abdominales et urine foncée."
}
},
{
"@type": "Question",
"name": "Comment prévenir le paludisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir la tuberculose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG et le dépistage précoce sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hépatite virale ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des comportements à risque sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour prévenir le VIH ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs, se faire dépister et suivre un traitement préventif."
}
},
{
"@type": "Question",
"name": "Comment prévenir la schistosomiase ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des eaux contaminées et améliorer l'assainissement."
}
},
{
"@type": "Question",
"name": "Quel traitement pour le paludisme ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'utilisation d'antipaludiques comme l'artémisinine."
}
},
{
"@type": "Question",
"name": "Comment traiter la tuberculose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement repose sur une combinaison d'antibiotiques sur plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'hépatite virale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des antiviraux et des soins de soutien selon le type."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection par le VIH ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement antirétroviral est essentiel pour contrôler l'infection et améliorer la vie."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la schistosomiase ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est le praziquantel, efficace contre les parasites."
}
},
{
"@type": "Question",
"name": "Quelles complications du paludisme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure anémie sévère, défaillance organique et coma."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, la fibrose pulmonaire et la dissémination."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'hépatite virale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure cirrhose, cancer du foie et insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Quelles complications du VIH ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections opportunistes et cancers liés à l'immunodéficience."
}
},
{
"@type": "Question",
"name": "Quelles complications de la schistosomiase ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure hypertension portale et troubles urinaires chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du paludisme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent vivre dans des zones endémiques et ne pas utiliser de protection."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la malnutrition, le VIH et le surpeuplement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hépatite virale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'usage de drogues injectables et les rapports sexuels non protégés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le VIH ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent les rapports sexuels non protégés et le partage de seringues."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la schistosomiase ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le contact avec des eaux douces contaminées et l'absence d'assainissement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/11/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Publications dans "Afrique du Nord" :
3 publications dans cette catégorie
Affiliations :
HIV/AIDS & Global Health Research Program, University of Venda, Thohoyandou, South Africa.
Publications dans "Afrique du Nord" :
3 publications dans cette catégorie
Affiliations :
HIV/AIDS & Global Health Research Program, University of Venda, Thohoyandou, South Africa.
Global Biomed Scientific LLC, PO Box 2368, Forest, VA 24551, USA.
Publications dans "Afrique du Nord" :
3 publications dans cette catégorie
Affiliations :
Epidemiology Section, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Department of Nutrition and Dietetics, University of the Free State, Bloemfontein, South Africa.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Agricultural Research Council, GeoInformatics Division, Natural Resources and Engineering, 600 Belvedere St., Pretoria 0083, South Africa.
Department of Geography, Geoinformatics and Meteorology, University of Pretoria, Pretoria 0028, South Africa.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental and Symbiotic Sciences, Rakuno Gakuen University, Ebetsu 069-8501, Japan.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
HIV/AIDS & Global Health Research Program, University of Venda, Thohoyandou, South Africa.
Center for Global Health Equity, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Department of Biological and Agricultural Sciences. Sol Plaatje University, Private Bag X5008, Kimberley, 8300, South Africa.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Mammal Research Institute, University of Pretoria, Pretoria 0028, South Africa.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Department of Anthropology, University of Colorado, Campus Box 233, Boulder, CO 80509, United States.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
SARChI Chair on Biodiversity Value and Change, Faculty of Science, Engineering and Agriculture, University of Venda, Thohoyandou 0950 South Africa.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
South African National Biodiversity Institute, P.O. Box 754, Pretoria, 0001, South Africa.
School of Health and Life Sciences, Teesside University, Middlesbrough,, TS1 3BA, United Kingdom.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
SARChI Chair on Biodiversity Value and Change, Faculty of Science, Engineering and Agriculture, University of Venda, Private Bag X5050, Thohoyandou, 0950, South Africa.
School of Life Sciences, Biological Sciences Building, University of KwaZulu-Natal, South Ring Road, Westville Campus, Durban, 3630, South Africa.
Zoology and Entomology Department, University of the Free State, Private Bag X13, Phuthaditjhaba, 9866, South Africa.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Department of Geography, West African Science Service Centre On Climate Change and Adapted Land Use (WASCAL), Faculty of Human and Social Sciences, University of Lomé, Lomé, Togo. gouvidejeang@gamil.com.
Department of Zoology, Laboratory of Ecology and Ecotoxicology, Faculty of Sciences, University of Lomé, 1BP: 1515, Lomé, Togo. gouvidejeang@gamil.com.
Publications dans "Afrique du Nord" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Kaba Laboratory of Chemical Research and Application (LaKReCA), Faculty of Science and Technic of Natitingou, University of Abomey, Abomey, Benin.
Publications dans "Afrique du Nord" :
Because of its location, North Africa (NA) has witnessed continuous demographic movements with an impact on the genomes of present-day human populations. Genomic data describe a complex scenario with ...
Key discoveries and innovations in the field of human genetics have led to the foundation of molecular and personalized medicine. Here, we present the Genome Tunisia Project, a two-phased initiative (...
A multidisciplinary partnership involving Tunisian experts from different institutions has come to discern all requirements that would be of high priority to fulfill the project's goals. One of the mo...
In the framework of this project, an ecosystem with all engaged stakeholders has been implemented including healthcare providers, clinicians, researchers, pharmacists, bioinformaticians, industry, pol...
Genome Tunisia is the first initiative in North Africa that seeks to demonstrate the major impact that can be achieved by Human Genome Projects in low- and middle-income countries to strengthen resear...
The most available data on the prevalence of cannabis use come from population surveys conducted in high-income countries in North America, Oceania and Europe. Less is known about the prevalence of ca...
A comprehensive search was conducted in PubMed, EMBASE, PsycINFO and AJOL databases in addition to Global Health Data Exchange and grey literature without language restriction. Search terms related to...
The study included 53 studies for the quantitative meta-analysis and included 13 239 participants. Among adolescents, the life-time, 12-month and 6-month prevalence of cannabis use were 7.9% [95% conf...
Life-time cannabis use prevalence in sub-Saharan Africa appears to be approximately 12% for adults and just under 8% for adolescents....
Mucopolysaccharidosis type I is a lysosomal storage disease resulting from a deficiency in alpha-L-iduronidase (IDUA), which causes the accumulation of partially degraded dermatan sulfate and heparan ...
All of the studied patients were from Libya (2), Mauritania (1) Morocco (21) and Tunisia (21) with first cousins being the most frequent union. The diagnosis of MPSI patients often involves the combin...
In the present report we confirmed the very strong impact of consanguinity on the incidence of MPSI disease. Furthermore, studied families of mixed ancestry shared common and specific haplotype, which...
The p.P533R missense mutation was identified in each patient originated from Libya, Mauritania, Morocco and Tunisia. Furthermore, these MPSI patients exhibited the same IDUA haplotype. The occurrence ...
Schizophrenia ranks as the third-most common cause of disability among mental disorders globally. This study presents findings on the prevalence, incidence and years lived with disability (YLDs) as a ...
Cutaneous leishmaniasis (CL) caused by infection with the parasite...
Road traffic injuries (RTIs) and deaths constitute a serious preventable global public health problem....
To analyse time trends of age-standardized mortality rates and disability-adjusted life years (DALYs) caused by RTIs in 23 Middle East and North Africa (MENA) countries; and to assess the correlation ...
Time trend analysis over 17 years (2000-2016) was conducted using Joinpoint regression. An overall score was calculated for each country to assess implementation of best practice for road safety....
Mortality decreased significantly (P < 0.05) in Islamic Republic of Iran, Jordan, Kuwait, Lebanon, Morocco, Oman, Qatar, and Tunisia. In most MENA countries, DALYs increased but they significantly dec...
Countries in the MENA region had varying levels of success in reducing the burden from RTIs. During the Decade of Action for Road Safety 2021-2030, MENA countries can achieve optimal road safety by im...
Coronary heart disease (CHD) is the leading cause of morbidity, mortality, and disability in the Middle East and North Africa (MENA). While the prevention, diagnosis, and management of CHD have been d...
Patients with CHD in the MENA feature younger age at presentation and worse prognosis in women. Despite the high burden of CHD risk factors, many of these factors remain underrecognized, undertreated,...
Gastric cancer (GC) ranks as the fifth most prevalent cancer and the fourth deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, GC represents about 4.8% of cancer cases with...
In the Middle East and North Africa (MENA) with extreme water scarcity worldwide, drought significantly impacts various aspects of the local people. This study uses the empirical multivariate standard...